跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Centranor - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Centranor
Approved
STANDARD
Centranor
Mefar İlaç San. A.Ş.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
f55ccf322fe73915
Company
Mefar İlaç San. A.Ş.
Type
Standard
Approval Details
Approval Id
f55ccf322fe73915
Drug Approval Philippines Name
Centranor
Product Name
Centranor
Registration Number
DRP-14873
Brand Name
Centranor
Generic Name
Norepinephrine (as bitartrate monohydrate)
Dosage Form
Concentrate for Solution for I.V. Infusion
Dosage Strength
1 mg/mL (4 mg/4 mL)
Manufacturer
Mefar İlaç San. A.Ş.
Trader
Pharmada İlaç San. Ve Tic A.Ş.
Importer
Grovic Pharma, Inc.
Distributor
Grovic Pharma, Inc.
Issuance Date
26 January 2024
Expiry Date
26 January 2029
Classification
Prescription (Rx) Drug
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
f55ccf322fe73915
Type
Standard
Back to Philippines FDA Approvals